UNSPSC 51281518: Bedaquiline

Definition: This classification is for a diarylquinolone used in the treatment of multi-drug resistant tuberculosis. BEDAQUILINE has a US FDA Unique Ingredient Identifier of 78846I289Y.

UNSPSC 51281518 Bedaquiline (Commodity) does not show material recent activity in state and local procurement. Of the recent opportunities tagged to this code, only one—Collier County Board of County Commissioners' Notice of Intent to Single Source Pediatric Emergency Standards, Inc. (Handtevy)—falls within the pharmaceutical and medical-supply domain; however, this opportunity concerns a mobile application for drug-dosage calculation and EMS protocol integration, not bedaquiline or any tuberculosis treatment. The remaining tagged opportunities span pharmacy benefits management, naloxone distribution, forensic drug standards, and facility management—none of which relate to bedaquiline procurement or therapeutic use.

The Collier County opportunity (PUR20975, single-source notice posted October 8, 2026, protest deadline September 24, 2026) demonstrates strong recent activity in EMS pharmaceutical technology integration within Florida county government, but the scope—real-time drug-dosing calculation and electronic patient care reporting integration—is entirely distinct from the procurement of bedaquiline itself. State and local solicitations for bedaquiline as a specialty tuberculosis pharmaceutical do not appear in the recent opportunities block. Firms targeting this code should monitor health departments and public health districts in states with elevated tuberculosis incidence, as well as county detention facilities and correctional departments that operate medical services, but current market signals suggest limited open procurement activity under this specific commodity classification.